Neurology
In neurology, Lusofarmaco presents an innovative molecule belonging to triptans' class; by virtue of some unique features, this drug is proposed as a reliable treatment for the control of migraines, particularly effective with relapsing episodes. In this area, Lusofarmaco's commitment is synonymous of continuity in tradition. Since 1956 – with the launch of one of the first drugs used for the treatment of schizophrenia, and subsequently of another molecule that is still today a reference drug for the antipsychotic class of medications, thus confirming at the beginning of the new millennium its undiscussed leadership in this sector of pharmaceutical industry – the list of products has gradually increased in number due to the inclusion of numerous molecules that not only guarantee coverage of many therapeutic areas, but also represent a true turning point in the pharmacological approach to the treatment of neuropsychiatric disorders.
| Brand
|
Active Ingredient
|
ATC
|
Pack
|
Reimbuersement Status
|
| AURADOL
|
Frovatriptan
|
Triptan
|
2 tablets 2,5 mg
|
Class: A
|
| 6 tablets 2,5 mg
|
Class: A
|
| ITALEPT
|
Levetiracetam
|
Antiepileptic
|
60 tablets 500 mg
|
Class: A
|
| 30 tablets 1.000 mg
|
Class: A
|
| 300 ml Oral Solution 100mg/ml
|
Class: A
|
| PRELYNCA
|
Pregabalin
|
Neurological Analgesics
|
Caps - 25 mg 14 CPS
|
Class: A04
|
| Caps - 75 mg 56 CPS
|
Class: A04
|
| Caps - 150 mg 56 CPS
|
Class: A04
|
| ROLDAP
|
Rasagiline
|
Antiparkinson
|
28 Tablets 1 mg
|
Class: A*
|
| SERENASE
|
Aloperidol
|
Antipsychotics
|
20 tablets 1 mg
|
Class: C
|
| drops 2 mg/ml 0,2% 15 ml
|
Class: C
|
| 20 tablets 5 mg
|
Class: A
|
| drops 10 mg/ml 1% 15 ml
|
Class: A
|
*Prescription subject to diagnosis and therapeutic plan drawn up by neurological centers